Le Lézard
Classified in: Health
Subject: MRR

Endoluminal Suturing Devices Market Expected to Flourish in Coming Years says Brandessence Market Research


LONDON, March 28, 2023 /PRNewswire/ -- The Global Endoluminal Suturing Devices Market is slated to amplify with a CAGR of 6.5% over the assessment timeline of 2022-2029.

BEMR Logo

Endoluminal suturing devices are referred to a type of medical devices which are equipped with the ability to close punctures or incisions in the walls of vessels or hollow body organs during a minimally invasive surgical process. These devices comprise of a catheter-like tube that is flexible in nature along with a needle at the end. This allows surgeons to insert these devices directly into the body through a small incision. They are particularly useful in procedures such as gastric bypass surgery, endoscopic suturing of gastrointestinal perforations, and closure of oesophageal fistulas, among others.

Get Sample of Report@ https://www.aimarketreport.com/downloadSample/PostId/167

Global Endoluminal Suturing Devices Market Outlook (2022-2029)

Growing pervasiveness of chronic ailments worldwide, escalating demand for minimally invasive surgeries, and technological advancements in the healthcare sector are primarily augmenting the outlook of this business sphere.

Furthermore, rising healthcare expenditure across various regions, increasing R&D investments in the field, along with the surge in the population of older adults are creating lucrative opportunities for this marketplace to prosper.

Alongside, rapidly improvements in the healthcare infrastructure of various nations, unhealthy lifestyle trends of the masses, and surge in medical tourism in developed countries are aiding the expansion of the Global Endoluminal Suturing Devices Market.

On the contrary, high cost of these devices and shortage of skilled medical professionals are hindering the remuneration of this industry vertical.     

Competitive Hierarchy

The prominent players characterizing the competitive terrain of the Global Endoluminal Suturing Devices Market are Apollo Endosurgery Inc., Ethicon Endo-Surgery, Boston Scientific Corporation, Medtronic plc, Cook Group Incorporated, USGI Medical Inc., Stryker Corporation, Thermo Fisher Scientific Inc., ErgoSuture, and Sutrue Ltd.

Segmental Outlook

By Application:

By Component:

By End User:

Get Methodology @ https://www.aimarketreport.com/requestMethodology/PostId/167

Region-Wise Outlook

Which is the leading region in the Global Endoluminal Suturing Devices Market?

North America is poised to lead the industry in terms of revenue share. This is due to the rising healthcare expenditure, growing prevalence of chronic ailments, surge in the geriatric population base, and the increasing practice od minimally invasive surgical procedures.

How is Asia Pacific faring in this industry?

Asia Pacific is slated to account for a significant market share over the estimated timeframe of 2022-2029. This is attributable to the rise in the geriatric population base, rapidly improving healthcare infrastructure, and influx of advanced technologies in this field.

Category-Wise Insights

Which is the fastest growing application segment in this business sphere?

The gastrointestinal surgery segment has emerged as one of the fastest growing application segments in this market. This is ascribed to the growing pervasiveness of gastrointestinal cancer across the globe.

Which is the most dominant end user segment in this marketplace?

The hospitals segment is presently dominating the market and is poised to showcase similar progression trends in the ensuing years. This is credited to the presence of skilled medical professionals and adequate medical equipment across hospitals.

Comparing the historical outlook and ongoing trends of this market

This marketplace has been generating significant returns over the stipulated timeframe due to the emergence of numerous expansion propellants.

There has been a rising prevalence of chronic diseases across the globe. With a rapid shift towards a more sedentary lifestyle and unhealthy dietary trends, many people are being diagnosed with lifestyle based and chronic ailments including obesity, gastrointestinal diseases, diabetes, and cancer, among others. Many patients suffering from such ailments require to undergo surgeries during the course of their treatment. This in turn is stimulating the overall dynamics of this business vertical.

The escalating demand for minimally invasive surgical procedures is another crucial growth stimulant for this industry sphere. As compared to traditional open surgeries, minimally invasive surgeries are safe for the patients since they are associated with lesser rates of infections. Apart from that, they also ensure fast recovery and shorter hospitals stays, thereby reducing a patient's overall healthcare expenditure. These factors together are positively swaying the outlook of this industry sphere.

Apart from that, there has been a rapid increase in the volume of geriatric population across the globe. It is evident that older adults are highly susceptible to chronic and lifestyle based diseases since they have a weakened immune system. They are also at a high risk of contracting infections when they undergo an open surgery. Therefore, minimally invasive surgery is ideal for older adults since it is safe in nature and ensures quicker recovery. This in turn is adding traction to the expansion of this market space during the stipulated timeframe of 2022-2029.

On Special Requirement Endoluminal Suturing Devices Market for Cancer Treatment Market Report is also available for below region:

North America

Europe

Asia-Pacific

Latin America

Middle East and Africa

Purchase Copy of Report @ https://www.aimarketreport.com/Checkout?report_id=167

Major Developments

In February 2021, Medtronic plc announced the acquisition of privately-held RF Surgical Systems, Inc. with an aim to enhance its portfolio of surgical products with the addition of RF technology for detection and prevention of retained surgical items.

Related Reports:

i-Factor: Live Market intelligence platform 

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at?https://brandessenceresearch.com/i-factor/login/userRegister 

Brandessence Market Research & Consulting Pvt ltd. 

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in?Pune, India?and our sales office is in?London. 

Follow Us:?Linkedin ?

M & A Advisory: Merger & Acquisition, and Capabilities

Blog:What is Market Research?
What is Market Sizing? How to Measure Your TAM, SAM, and SOM

Contact: 
Mr.?Vishal Sawant? 
Email:?[email protected]? 
Email:?[email protected]? 
Corporate Sales:?+44-2038074155? 
Asia Office:?+917447409162 

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

 

SOURCE Brandessence Market Research and Consulting Private Limited


These press releases may also interest you

at 11:37
Union Construction Industry Unites to Combat Substance Use Disorder and Build Mental Wellness at 4th Annual BTEA Recovery Week
According to data from the CDC, the construction industry has the highest overdose death rate across all industries1. Construction workers are five times more likely to die by suicide than safety-related issues2. BTEA is uniting the union...

at 11:35
A2 Bio to Highlight Progress of CAR T Clinical Programs in Three Poster Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
A2 Biotherapeutics, Inc. (A2 Bio) a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today announced the acceptance of three posters for presentation...

at 11:28
New England's Premier Oral Surgery Practice Joins Qualitas Dental Partners
Qualitas Dental Partners proudly announces its partnership with the foremost oral surgery group in New England, furthering its commitment to deliver patient-centric dental care across the region....

at 11:25
MAKO Medical Partners with Rebuilding Together to Restore Home for U.S. Military Veteran
MAKO Medical, a leader in healthcare diagnostics and laboratory services, is honored to announce its partnership with Rebuilding Together, a renowned nonprofit organization focused on repairing homes, revitalizing communities, and rebuilding lives....

at 11:20
Antibe Announces Appointment of Receiver
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company's request for an extension of its previously announced stay of proceedings under the Companies' Creditors Arrangement Act (the "CCAA") was heard before the Ontario...

at 11:15
New Research to Examine the Role of Pet Dogs for the Resilience and Wellbeing of Military Adolescents
The Human Animal Bond Research Institute (HABRI) today announced a new grant for research that investigates the contribution of pet dog ownership to resilience and well-being in adolescent children of military families. This grant was awarded to a...

More news about Health...


News published on and distributed by: